Listed

Microbot Medical Inc.

MBOTNasdaqCIK 883975HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$241.0k, Q2 FY2026
Operating income−$6.2m, Q2 FY2026
Net income−$5.6m, Q2 FY2026
Microbot Medical Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported105Revenue, Q1 FY2026, three months to 2026-03-31$105.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure241Revenue, Q2 FY2026, three months to 2026-06-30$241.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Cost of revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported103Cost of revenue, Q1 FY2026, three months to 2026-03-31$103.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure884Cost of revenue, Q2 FY2026, three months to 2026-06-30$884.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Gross profit$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported2.0Gross profit, Q1 FY2026, three months to 2026-03-31$2.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(643)Gross profit, Q2 FY2026, three months to 2026-06-30−$643.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Research and development$k1,612Research and development, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure1,130Research and development, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-25, accession 0001641172-25-000614. Derived: 12-month figure less the 9-month figure.Report this figure1,169Research and development, Q1 FY2024, three months to 2024-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure1,417Research and development, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure2,060Research and development, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure1,984Research and development, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure1,459Research and development, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure2,111Research and development, Q2 FY2025, three months to 2025-06-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure1,171Research and development, Q3 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure1,542Research and development, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure1,293Research and development, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure1,861Research and development, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Selling, general and administrative$knot reportednot reportednot reportednot reportednot reportednot reported1,562Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure1,612Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figurenot reportednot reported3,029Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure3,684Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$3.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Operating income$k(2,544)Operating income, Q3 FY2023, three months to 2023-09-30−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure(2,068)Operating income, Q4 FY2023, three months to 2023-12-31−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-25, accession 0001641172-25-000614. Derived: 12-month figure less the 9-month figure.Report this figure(2,384)Operating income, Q1 FY2024, three months to 2024-03-31−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure(2,511)Operating income, Q2 FY2024, three months to 2024-06-30−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure(3,300)Operating income, Q3 FY2024, three months to 2024-09-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure(3,430)Operating income, Q4 FY2024, three months to 2024-12-31−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure(3,021)Operating income, Q1 FY2025, three months to 2025-03-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(3,723)Operating income, Q2 FY2025, three months to 2025-06-30−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure(3,861)Operating income, Q3 FY2025, three months to 2025-09-30−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure(4,138)Operating income, Q4 FY2025, three months to 2025-12-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure(4,320)Operating income, Q1 FY2026, three months to 2026-03-31−$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(6,188)Operating income, Q2 FY2026, three months to 2026-06-30−$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(2,446)Net income, Q3 FY2023, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure(3,154)Net income, Q4 FY2023, three months to 2023-12-31−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-25, accession 0001641172-25-000614. Derived: 12-month figure less the 9-month figure.Report this figure(2,371)Net income, Q1 FY2024, three months to 2024-03-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure(2,465)Net income, Q2 FY2024, three months to 2024-06-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure(3,215)Net income, Q3 FY2024, three months to 2024-09-30−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure(3,392)Net income, Q4 FY2024, three months to 2024-12-31−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure(2,601)Net income, Q1 FY2025, three months to 2025-03-31−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure(3,500)Net income, Q2 FY2025, three months to 2025-06-30−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure(3,577)Net income, Q3 FY2025, three months to 2025-09-30−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure(3,464)Net income, Q4 FY2025, three months to 2025-12-31−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure(3,671)Net income, Q1 FY2026, three months to 2026-03-31−$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure(5,627)Net income, Q2 FY2026, three months to 2026-06-30−$5.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Diluted EPS$ per share(0.21)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure(0.17)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure(0.20)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figurenot reported(0.08)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(0.10)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure(0.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figurenot reported(0.05)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Basic EPS$ per share(0.21)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figurenot reported(0.17)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure(0.17)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure(0.20)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figurenot reported(0.08)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(0.10)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure(0.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figurenot reported(0.05)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure

Balance sheet

Cash and equivalents$3.2m, Q2 FY2026
Shareholders' equity$68.9m, Q2 FY2026
Microbot Medical Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m1.3Cash and equivalents, Q3 FY2023, at 2023-09-30$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001493152-23-041069.Report this figure2.5Cash and equivalents, FY2023, at 2023-12-31$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-25, accession 0001641172-25-000614.Report this figure1.2Cash and equivalents, Q1 FY2024, at 2024-03-31$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001493152-24-019535.Report this figure2.5Cash and equivalents, Q2 FY2024, at 2024-06-30$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure0.5Cash and equivalents, Q3 FY2024, at 2024-09-30$479.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure3.1Cash and equivalents, FY2024, at 2024-12-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001493152-26-012935.Report this figure3.2Cash and equivalents, Q1 FY2025, at 2025-03-31$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure4.1Cash and equivalents, Q2 FY2025, at 2025-06-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure6.7Cash and equivalents, Q3 FY2025, at 2025-09-30$6.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure3.9Cash and equivalents, FY2025, at 2025-12-31$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure3.7Cash and equivalents, Q1 FY2026, at 2026-03-31$3.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure3.2Cash and equivalents, Q2 FY2026, at 2026-06-30$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Current assets$m8.4Current assets, Q3 FY2023, at 2023-09-30$8.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041069.Report this figure7.9Current assets, FY2023, at 2023-12-31$7.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-25, accession 0001641172-25-000614.Report this figure7.0Current assets, Q1 FY2024, at 2024-03-31$7.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019535.Report this figure7.1Current assets, Q2 FY2024, at 2024-06-30$7.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032031.Report this figure5.0Current assets, Q3 FY2024, at 2024-09-30$5.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure5.8Current assets, FY2024, at 2024-12-31$5.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001493152-26-012935.Report this figure30.7Current assets, Q1 FY2025, at 2025-03-31$30.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure32.9Current assets, Q2 FY2025, at 2025-06-30$32.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure80.8Current assets, Q3 FY2025, at 2025-09-30$80.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure79.8Current assets, FY2025, at 2025-12-31$79.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure76.5Current assets, Q1 FY2026, at 2026-03-31$76.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure72.2Current assets, Q2 FY2026, at 2026-06-30$72.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Total assets$m8.9Total assets, Q3 FY2023, at 2023-09-30$8.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001493152-23-041069.Report this figure8.3Total assets, FY2023, at 2023-12-31$8.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-25, accession 0001641172-25-000614.Report this figure7.4Total assets, Q1 FY2024, at 2024-03-31$7.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001493152-24-019535.Report this figure7.4Total assets, Q2 FY2024, at 2024-06-30$7.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001493152-24-032031.Report this figure5.2Total assets, Q3 FY2024, at 2024-09-30$5.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure6.0Total assets, FY2024, at 2024-12-31$6.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001493152-26-012935.Report this figure30.9Total assets, Q1 FY2025, at 2025-03-31$30.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure33.1Total assets, Q2 FY2025, at 2025-06-30$33.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure81.8Total assets, Q3 FY2025, at 2025-09-30$81.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure81.5Total assets, FY2025, at 2025-12-31$81.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure78.1Total assets, Q1 FY2026, at 2026-03-31$78.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure73.4Total assets, Q2 FY2026, at 2026-06-30$73.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Current liabilities$m1.5Current liabilities, Q3 FY2023, at 2023-09-30$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041069.Report this figure3.8Current liabilities, FY2023, at 2023-12-31$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-25, accession 0001641172-25-000614.Report this figure1.2Current liabilities, Q1 FY2024, at 2024-03-31$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019535.Report this figure1.3Current liabilities, Q2 FY2024, at 2024-06-30$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032031.Report this figure1.4Current liabilities, Q3 FY2024, at 2024-09-30$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure2.5Current liabilities, FY2024, at 2024-12-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001493152-26-012935.Report this figure1.9Current liabilities, Q1 FY2025, at 2025-03-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure2.7Current liabilities, Q2 FY2025, at 2025-06-30$2.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure2.9Current liabilities, Q3 FY2025, at 2025-09-30$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure3.4Current liabilities, FY2025, at 2025-12-31$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure3.4Current liabilities, Q1 FY2026, at 2026-03-31$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure3.9Current liabilities, Q2 FY2026, at 2026-06-30$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Total liabilities$m1.5Total liabilities, Q3 FY2023, at 2023-09-30$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001493152-23-041069.Report this figure3.8Total liabilities, FY2023, at 2023-12-31$3.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-25, accession 0001641172-25-000614.Report this figure1.2Total liabilities, Q1 FY2024, at 2024-03-31$1.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001493152-24-019535.Report this figure1.4Total liabilities, Q2 FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001493152-24-032031.Report this figure1.4Total liabilities, Q3 FY2024, at 2024-09-30$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure2.5Total liabilities, FY2024, at 2024-12-31$2.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001493152-26-012935.Report this figure1.9Total liabilities, Q1 FY2025, at 2025-03-31$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure2.8Total liabilities, Q2 FY2025, at 2025-06-30$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure3.5Total liabilities, Q3 FY2025, at 2025-09-30$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure4.0Total liabilities, FY2025, at 2025-12-31$4.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure4.0Total liabilities, Q1 FY2026, at 2026-03-31$4.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure4.4Total liabilities, Q2 FY2026, at 2026-06-30$4.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m7.4Shareholders' equity, Q3 FY2023, at 2023-09-30$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure4.5Shareholders' equity, FY2023, at 2023-12-31$4.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001493152-26-012935.Report this figure6.2Shareholders' equity, Q1 FY2024, at 2024-03-31$6.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure6.1Shareholders' equity, Q2 FY2024, at 2024-06-30$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure3.8Shareholders' equity, Q3 FY2024, at 2024-09-30$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure3.5Shareholders' equity, FY2024, at 2024-12-31$3.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure29.0Shareholders' equity, Q1 FY2025, at 2025-03-31$29.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure30.4Shareholders' equity, Q2 FY2025, at 2025-06-30$30.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure78.2Shareholders' equity, Q3 FY2025, at 2025-09-30$78.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure77.6Shareholders' equity, FY2025, at 2025-12-31$77.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure74.1Shareholders' equity, Q1 FY2026, at 2026-03-31$74.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure68.9Shareholders' equity, Q2 FY2026, at 2026-06-30$68.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure

Cash flow

Operating cash flow−$5.0m, Q2 FY2026
Capital expenditure$142.0k, Q2 FY2026
Microbot Medical Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(1,655)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001493152-24-045136. Derived: 9-month figure less the 6-month figure.Report this figure(1,821)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-25, accession 0001641172-25-000614. Derived: 12-month figure less the 9-month figure.Report this figure(2,420)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure(1,957)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001641172-25-023206. Derived: 6-month figure less the 3-month figure.Report this figure(2,759)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021929. Derived: 9-month figure less the 6-month figure.Report this figure(1,691)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure(2,874)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(2,573)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-037009. Derived: 6-month figure less the 3-month figure.Report this figure(3,841)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021929. Derived: 9-month figure less the 6-month figure.Report this figure(3,758)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure(5,053)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure(4,989)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-037009. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k28.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$28.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001493152-24-045136. Derived: 9-month figure less the 6-month figure.Report this figure(5.0)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-25, accession 0001641172-25-000614. Derived: 12-month figure less the 9-month figure.Report this figure14.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure4.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001641172-25-023206. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021929. Derived: 9-month figure less the 6-month figure.Report this figure7.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure13.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure9.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-037009. Derived: 6-month figure less the 3-month figure.Report this figure13.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021929. Derived: 9-month figure less the 6-month figure.Report this figure25.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$25.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001493152-26-012935. Derived: 12-month figure less the 9-month figure.Report this figure108Capital expenditure, Q1 FY2026, three months to 2026-03-31$108.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure142Capital expenditure, Q2 FY2026, three months to 2026-06-30$142.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-037009. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)67.16m, Q2 FY2026
Microbot Medical Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares7.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-307,108,133 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-041069.Report this figure8.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-318,013,295 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001493152-24-019535.Report this figure9.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-309,198,806 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001493152-24-032031.Report this figure11.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3011,707,317 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001493152-24-045136.Report this figure14.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3114,055,973 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001641172-25-010277.Report this figure14.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3014,846,584 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001641172-25-023206.Report this figure16.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3016,471,419 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure31.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3131,085,606 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure36.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3036,488,014 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure48.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3048,095,384 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021929.Report this figure67.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3167,158,044 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022792.Report this figure67.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3067,163,613 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure

Shares outstanding: 67.16mShares outstanding, period not labelled, at 2026-08-1167,164,801 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-037009.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.